Stratos Wealth Partners LTD. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,713 shares of the healthcare conglomerate’s stock after selling 325 shares during the period. Stratos Wealth Partners LTD.’s holdings in UnitedHealth Group were worth $4,358,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also made changes to their positions in the stock. FMR LLC increased its stake in UnitedHealth Group by 0.6% during the 4th quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock worth $18,433,841,000 after buying an additional 295,642 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of UnitedHealth Group by 5.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock worth $13,318,678,000 after purchasing an additional 1,881,407 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of UnitedHealth Group by 5.2% during the 4th quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock worth $4,027,639,000 after purchasing an additional 569,142 shares during the last quarter. Norges Bank acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $3,397,896,000. Finally, Bank of New York Mellon Corp boosted its holdings in shares of UnitedHealth Group by 2.4% during the 4th quarter. Bank of New York Mellon Corp now owns 8,858,179 shares of the healthcare conglomerate’s stock worth $3,106,385,000 after purchasing an additional 207,865 shares during the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.
In other news, EVP Patricia L. Lewis sold 3,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, April 16th. The shares were sold at an average price of $389.99, for a total value of $1,169,970.00. Following the sale, the executive vice president now directly owns 9,214 shares in the company, valued at $3,593,367.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 619 shares of the business’s stock in a transaction on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total transaction of $200,494.10. Following the transaction, the chief accounting officer now owns 31,908 shares in the company, valued at $10,335,001.20. The disclosure for this sale can be found here. Insiders have sold a total of 20,420 shares of company stock worth $7,532,962 in the last three months. 0.80% of the stock is owned by insiders.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.38 by $0.93. The company had revenue of $70.20 billion during the quarter, compared to analysts’ expectations of $69.13 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business’s revenue was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.72 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.23%. The ex-dividend date of this dividend was Friday, March 12th. UnitedHealth Group’s payout ratio is 33.09%.
A number of research firms recently commented on UNH. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $450.00 price objective on the stock in a report on Tuesday, April 27th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $409.00 to $418.00 and gave the company a “buy” rating in a report on Thursday, April 22nd. Mizuho upped their price target on UnitedHealth Group from $380.00 to $394.00 and gave the stock a “buy” rating in a research note on Thursday, April 15th. Stephens upped their price target on UnitedHealth Group from $415.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, April 22nd. Finally, Barclays upped their price target on UnitedHealth Group from $405.00 to $435.00 and gave the stock an “overweight” rating in a research note on Thursday, April 22nd. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $409.61.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Recommended Story: Support Level
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.